Jeremy Bender

Insider Reports History

Entity
Individual
Location
395 Oyster Point Blvd., Suite 217, South San Francisco, CA
Signature
/s/ Charles N. York II, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jeremy Bender:

Insider Reports Filed by Jeremy Bender

Symbol Company Period Transactions Value $ Form Type Date Filed Role
DAWN Day One Biopharmaceuticals, Inc. Nov 15, 2024 7 -$139K 4 Nov 19, 2024 CHIEF EXECUTIVE OFFICER, Director
DAWN Day One Biopharmaceuticals, Inc. Aug 15, 2024 7 -$150K 4 Aug 19, 2024 CHIEF EXECUTIVE OFFICER, Director
DAWN Day One Biopharmaceuticals, Inc. Jul 2, 2024 8 $0 4 Jul 5, 2024 CHIEF EXECUTIVE OFFICER, Director
MREO Mereo BioPharma Group plc Jun 17, 2024 1 $50.1K 4 Jun 17, 2024 Director
FUSN Fusion Pharmaceuticals Inc. Jun 4, 2024 1 $0 4 Jun 4, 2024 Director
DAWN Day One Biopharmaceuticals, Inc. May 15, 2024 7 -$127K 4 May 17, 2024 CHIEF EXECUTIVE OFFICER, Director
DAWN Day One Biopharmaceuticals, Inc. May 1, 2024 3 -$1.42M 4 May 3, 2024 CHIEF EXECUTIVE OFFICER, Director
DAWN Day One Biopharmaceuticals, Inc. Feb 15, 2024 7 -$116K 4 Feb 20, 2024 CHIEF EXECUTIVE OFFICER, Director
MREO Mereo BioPharma Group plc Feb 8, 2024 2 $0 4 Feb 9, 2024 Director
DAWN Day One Biopharmaceuticals, Inc. Jan 5, 2024 2 $0 4 Jan 9, 2024 Chief Executive Officer, Director
MREO Mereo Biopharma Group plc Jan 1, 2024 0 $0 3 Jan 2, 2024 Director
DAWN Day One Biopharmaceuticals, Inc. Nov 15, 2023 5 -$36.3K 4 Nov 17, 2023 Chief Executive Officer, Director
FUSN Fusion Pharmaceuticals Inc. Oct 16, 2023 1 $0 4 Oct 16, 2023 Director
FUSN Fusion Pharmaceuticals Inc. Oct 16, 2023 0 $0 3 Oct 16, 2023 Director
DAWN Day One Biopharmaceuticals, Inc. Aug 15, 2023 5 -$41.5K 4 Aug 17, 2023 Chief Executive Officer, Director
DAWN Day One Biopharmaceuticals, Inc. Jul 1, 2023 10 $0 4 Jul 5, 2023 Chief Executive Officer, Director
DAWN Day One Biopharmaceuticals, Inc. May 15, 2023 5 -$40.7K 4 May 17, 2023 Chief Executive Officer, Director
DAWN Day One Biopharmaceuticals, Inc. Mar 7, 2023 1 -$250K 4 Mar 8, 2023 Chief Executive Officer, Director
DAWN Day One Biopharmaceuticals, Inc. Feb 15, 2023 5 -$59.1K 4 Feb 17, 2023 Chief Executive Officer, Director
DAWN Day One Biopharmaceuticals, Inc. Jan 23, 2023 1 -$275K 4 Jan 24, 2023 Chief Executive Officer, Director
DAWN Day One Biopharmaceuticals, Inc. Jan 17, 2023 2 $0 4 Jan 19, 2023 Chief Executive Officer, Director
DAWN Day One Biopharmaceuticals, Inc. Dec 31, 2022 4 $0 5 Feb 13, 2023 Chief Executive Officer, Director
DAWN Day One Biopharmaceuticals, Inc. Dec 21, 2022 1 -$254K 4 Dec 22, 2022 Chief Executive Officer, Director
DAWN Day One Biopharmaceuticals, Inc. Nov 21, 2022 2 -$259K 4 Nov 22, 2022 Chief Executive Officer, Director
DAWN Day One Biopharmaceuticals, Inc. Nov 15, 2022 3 -$32.5K 4 Nov 17, 2022 Chief Executive Officer, Director
DAWN Day One Biopharmaceuticals, Inc. Nov 1, 2022 1 -$250K 4 Nov 3, 2022 Chief Executive Officer, Director
DAWN Day One Biopharmaceuticals, Inc. Oct 3, 2022 1 -$251K 4 Oct 5, 2022 Chief Executive Officer, Director
DAWN Day One Biopharmaceuticals, Inc. Sep 1, 2022 2 -$291K 4 Sep 6, 2022 Chief Executive Officer, Director
DAWN Day One Biopharmaceuticals, Inc. Sep 1, 2022 2 -$291K 4 Sep 6, 2022 Chief Executive Officer, Director
DAWN Day One Biopharmaceuticals, Inc. Aug 15, 2022 3 -$97.3K 4 Aug 17, 2022 Chief Executive Officer, Director
DAWN Day One Biopharmaceuticals, Inc. Aug 4, 2022 1 -$250K 4 Aug 5, 2022 Chief Executive Officer, Director
DAWN Day One Biopharmaceuticals, Inc. Jul 18, 2022 1 -$52K 4 Jul 20, 2022 Chief Executive Officer, Director
DAWN Day One Biopharmaceuticals, Inc. Jul 8, 2022 1 -$35.9K 4 Jul 12, 2022 Chief Executive Officer, Director
DAWN Day One Biopharmaceuticals, Inc. Jul 1, 2022 2 -$52.1K 4 Jul 6, 2022 Chief Executive Officer, Director
DAWN Day One Biopharmaceuticals, Inc. Jan 18, 2022 2 $0 4 Jan 20, 2022 Chief Executive Officer, Director
DAWN Day One Biopharmaceuticals, Inc. May 26, 2021 0 $0 3 May 26, 2021 Chief Executive Officer, Director